Seacoast Banking Corporation of Florida filings document the regulatory record of a Florida bank holding company whose principal operating subsidiary is Seacoast National Bank. Its 8-K reports furnish quarterly and annual results, investor presentations, Regulation FD materials, securities-portfolio actions and other material events tied to bank earnings, deposits, net interest income, capital and liquidity.
Proxy and governance filings describe annual meeting matters, board composition, director elections, compensation and shareholder voting items. Transaction and capital-structure disclosures document completed bank acquisitions, amendments related to Series A Non-Voting Preferred Stock, rights of security holders and other matters affecting Seacoast's common and preferred equity.
SEACOAST BANKING CORP OF FLORIDA reports that subsidiary director H. Gilbert Culbreth Jr. was granted 2,015 shares of common stock on 2026-07-31 at 34.7400 per share as restricted stock for 2026 board service, deferred into the company’s directors deferred compensation plan. He also holds a right to buy 2,142 common shares at an exercise price of 22.6500 until 2027-02-06, plus various direct and indirect holdings including 26,000 shares in a family limited liability company and 8,200 shares in a family sub-S corporation.
Lipstein Robert J reported acquisition or exercise transactions in this Form 4 filing.
Seacoast Banking Corp of Florida director Robert J. Lipstein received a grant of 2,015 shares of common stock on July 31, 2026, valued at $34.74 per share, as stock issued from Seacoast's 2021 Incentive Plan for Board services in 2026. Footnotes indicate certain reported holdings are held jointly with his spouse and in an IRA.
Seacoast Banking Corp of Florida Chairman, President & CEO Charles M. Shaffer exercised stock rights for 28,544 shares of common stock at an exercise price of $28.69 per share on 2026-08-04. To fund the exercise and related tax withholding, he sold 25,851 shares at a weighted average price of $35.47 per share. He also continues to hold options on 18,952 shares at $31.15 per share, expiring in 2028, plus various unvested restricted stock and plan-based share holdings.
Seacoast Banking Corporation of Florida reported net income of $59.5 million for the quarter ended June 30, 2026, up from $42.7 million a year earlier. Net interest income rose to $180.4 million as interest income growth outpaced higher funding costs, while diluted EPS was $0.55 versus $0.50.
Total assets reached $21.36 billion at June 30, 2026, with loans of $13.15 billion and deposits of $16.79 billion, including balances added from the 2025 Villages Bancorporation and Heartland acquisitions. Credit quality remained manageable: nonaccrual loans were $86.5 million and the allowance for credit losses was $182.1 million, or 1.38% of loans held for investment.
Results were affected by securities repositioning; during the first half of 2026 the company realized net securities losses of $39.6 million on $277.2 million of available-for-sale sales, which significantly reduced noninterest income. Regulatory capital ratios at both the holding company and Seacoast Bank exceeded well-capitalized requirements under the Basel III framework.
Seacoast Banking Corporation of Florida reported Q2 2026 net income of $59.5 million, or $0.55 per diluted share, up 87% from the prior quarter and 39% from a year earlier. Adjusted net income was $65.8 million, or $0.61 per diluted share. Net revenues were $208.2 million, with net interest income of $180.4 million, up 42% year over year.
Net interest margin held at 3.83%, and excluding accretion on acquired loans rose to 3.65%. Loans grew at a 16% annualized rate, while deposits increased 3.7% annualized and cost of deposits fell to 1.53%. Asset quality remained solid, with nonperforming loans at 0.66% of total loans and net charge-offs of $3.2 million. The balance sheet showed $21.4 billion in assets, a Tier 1 capital ratio of 14.3%, tangible equity to tangible assets of 9.25%, and $9.2 billion of available borrowing capacity. The company repurchased 751,680 shares in the quarter.
Seacoast Banking Corporation of Florida director H. Gilbert Culbreth Jr reported a stock grant of 390 shares of Common Stock. The award, coded as an acquisition, was granted at $31.66 per share and increased his directly held Common Stock to 49,982.66 shares.
In addition to these direct holdings, the filing lists indirect ownership through a family S-corporation and a family limited liability company, as well as various joint and retirement accounts. Culbreth also holds a Common Stock Right to Buy covering 2,142 underlying shares at an exercise price of $22.65 per share, expiring on February 6, 2027. The grant was made pursuant to Seacoast Banking Corporation of Florida's 2013 Incentive Plan and reflects routine director compensation rather than an open-market purchase.
SEACOAST BANKING CORP OF FLORIDA director Dennis S. Hudson III reported an open-market sale of Seacoast common stock. On July 1, 2026, he sold 4,000 shares of Common Stock at $34.00 per share in a transaction described as a sale in the open market or a private transaction.
The filing states the sale was effected under a Rule 10b5-1 trading plan adopted on November 21, 2025. Following the sale, he directly holds 216,854 shares of Common Stock. The report also lists additional indirect holdings through a family partnership and a spouse’s trust, plus outstanding stock options labeled as Common Stock Rights to Buy with exercise prices of $28.69 and $31.15 expiring in 2027 and 2028.
Dennis S Hudson III Revocable Trust filed a Form 144 notice to sell common shares. The filing lists a sale of 8,000 common shares on 06/16/2026 with proceeds of $251,316.80. The record also shows 3,927 exercised shares on 12/19/2023 and 73 performance shares dated 02/22/2019.
Seacoast Banking Corp of Florida director Dennis S. Hudson III reported an open‑market sale of 8,000 shares of Common Stock at a weighted average price of $31.41 per share on June 16, 2026. The shares were sold in multiple transactions at prices between $31.20 and $31.64 under a pre‑arranged Rule 10b5‑1 trading plan adopted on November 21, 2025.
After this sale, Hudson directly holds 220,854 shares of Seacoast common stock and also reports additional indirect holdings, including shares held by a family partnership and in a spouse’s trust. He continues to hold stock options covering 78,021 shares at an exercise price of $28.69 expiring on April 1, 2027, and 55,279 shares at an exercise price of $31.15 expiring on April 1, 2028.